These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 20671219)

  • 1. Hemoglobin A1c in hemodialysis patients: should one size fit all?
    Ix JH
    Clin J Am Soc Nephrol; 2010 Sep; 5(9):1539-41. PubMed ID: 20671219
    [No Abstract]   [Full Text] [Related]  

  • 2. Glycemic control and extended hemodialysis survival in patients with diabetes mellitus: comparative results of traditional and time-dependent Cox model analyses.
    Williams ME; Lacson E; Wang W; Lazarus JM; Hakim R
    Clin J Am Soc Nephrol; 2010 Sep; 5(9):1595-601. PubMed ID: 20671217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there a U-shaped curve of A1c versus mortality?
    Bloomgarden ZT; Drexler A
    J Diabetes; 2012 Jun; 4(2):107-8. PubMed ID: 22443259
    [No Abstract]   [Full Text] [Related]  

  • 4. An interview with the authors of "Is there a U-shaped curve of A1c vs. mortality?".
    Bloomgarden Z; Drexler A
    J Diabetes; 2012 Jun; 4(2):109. PubMed ID: 22583822
    [No Abstract]   [Full Text] [Related]  

  • 5. Glycated albumin and continuous glucose monitoring to replace glycated haemoglobin in patients with diabetes treated with haemodialysis.
    Meyer L; Chantrel F; Imhoff O; Sissoko A; Serb L; Dorey F; Fleury D; Smagala A; Kepenekian L; Krummel T; Le Floch JP; Kessler L
    Diabet Med; 2013 Nov; 30(11):1388-9. PubMed ID: 23909880
    [No Abstract]   [Full Text] [Related]  

  • 6. Glycated albumin and risk of death and hospitalizations in diabetic dialysis patients.
    Freedman BI; Andries L; Shihabi ZK; Rocco MV; Byers JR; Cardona CY; Pickard MA; Henderson DL; Sadler MV; Courchene LM; Jordan JR; Balderston SS; Graham AD; Mauck VL; Russell GB; Bleyer AJ
    Clin J Am Soc Nephrol; 2011 Jul; 6(7):1635-43. PubMed ID: 21597024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Significance of hemoglobin A1C in the management of diabetes in dialysis patients].
    Mácsai E; Rakk E; Miléder M; Fulcz A
    Orv Hetil; 2014 Sep; 155(36):1421-5. PubMed ID: 25176516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring.
    Vos FE; Schollum JB; Coulter CV; Manning PJ; Duffull SB; Walker RJ
    Nephrology (Carlton); 2012 Feb; 17(2):182-8. PubMed ID: 21883672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dialysis: Glycated albumin or HbA(1c) in dialysis patients with diabetes?
    Biesenbach G; Pohanka E
    Nat Rev Nephrol; 2011 Aug; 7(9):490-2. PubMed ID: 21808280
    [No Abstract]   [Full Text] [Related]  

  • 10. Transplantation, hemodialysis, and continuous ambulatory peritoneal dialysis for end-stage renal disease in diabetic patients.
    Jacobson SH; Fryd D; Lins LE; Matson M; Sutherland DE; Kjellstrand CM
    J Diabet Complications; 1988; 2(3):150-7. PubMed ID: 2975666
    [No Abstract]   [Full Text] [Related]  

  • 11. Significant inverse relationship between serum undercarboxylated osteocalcin and glycemic control in maintenance hemodialysis patients.
    Okuno S; Ishimura E; Tsuboniwa N; Norimine K; Yamakawa K; Yamakawa T; Shoji S; Mori K; Nishizawa Y; Inaba M
    Osteoporos Int; 2013 Feb; 24(2):605-12. PubMed ID: 22581293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unique hemoglobin A1c level distribution and its relationship with mortality in diabetic hemodialysis patients.
    Hoshino J; Larkina M; Karaboyas A; Bieber BA; Ubara Y; Takaichi K; Akizawa T; Akiba T; Fukuhara S; Pisoni RL; Saito A; Robinson BM
    Kidney Int; 2017 Aug; 92(2):497-503. PubMed ID: 28396123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum albumin-adjusted glycated albumin is a better predictor of mortality in diabetic patients with end-stage renal disease on hemodialysis.
    Yajima T; Yajima K; Hayashi M; Yasuda K; Takahashi H; Yamakita N
    J Diabetes Complications; 2016 Jul; 30(5):786-9. PubMed ID: 27009773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decrease mortality in type II diabetes mellitus: glycemic and renal function control.
    Borghi C; Ventura F
    J Cardiovasc Med (Hagerstown); 2018 Feb; 19 Suppl 1():e13-e15. PubMed ID: 29538138
    [No Abstract]   [Full Text] [Related]  

  • 15. Assessment of glycemic control in dialysis patients with diabetes: glycosylated hemoglobin or glycated albumin?
    Mehrotra R; Kalantar-Zadeh K; Adler S
    Clin J Am Soc Nephrol; 2011 Jul; 6(7):1520-2. PubMed ID: 21734081
    [No Abstract]   [Full Text] [Related]  

  • 16. Quantification of HDL proteins, cardiac events, and mortality in patients with type 2 diabetes on hemodialysis.
    Kopecky C; Genser B; Drechsler C; Krane V; Kaltenecker CC; Hengstschläger M; März W; Wanner C; Säemann MD; Weichhart T
    Clin J Am Soc Nephrol; 2015 Feb; 10(2):224-31. PubMed ID: 25424990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Which hypoglycaemic agents to use in type 2 diabetic subjects with CKD and how?
    Haneda M; Morikawa A
    Nephrol Dial Transplant; 2009 Feb; 24(2):338-41. PubMed ID: 19015168
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of smoking on the survival rate of diabetic patients requiring hemodialysis.
    Biesenbach G; Zazgornik J
    Diabetes Care; 1996 Jun; 19(6):625-8. PubMed ID: 8725862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycemic control in diabetic dialysis patients and the burnt-out diabetes phenomenon.
    Park J; Lertdumrongluk P; Molnar MZ; Kovesdy CP; Kalantar-Zadeh K
    Curr Diab Rep; 2012 Aug; 12(4):432-9. PubMed ID: 22638938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intensive therapy in type 2 diabetes. More damage than benefit?].
    Einecke D
    MMW Fortschr Med; 2008 Jun; 150(26-27):12-4. PubMed ID: 18681224
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.